Atlas Trials

A Single Dose Study of Oral Vadadustat in Subjects With Normal and Impaired Hepatic Function

Clinical trial NCT03799848 · COMPLETED

Trial details

NCT number
NCT03799848
Sponsor
Akebia Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatic Impairment
Start date
2018-06-12
Primary completion
2018-10-18
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.